7-102884272-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000440067.4(FBXL13):c.1319C>A(p.Thr440Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,613,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000440067.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL13 | NM_001394494.2 | c.1319C>A | p.Thr440Asn | missense_variant | 13/21 | ENST00000440067.4 | NP_001381423.1 | |
FBXL13 | NR_105043.2 | n.1345C>A | non_coding_transcript_exon_variant | 13/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL13 | ENST00000440067.4 | c.1319C>A | p.Thr440Asn | missense_variant | 13/21 | 3 | NM_001394494.2 | ENSP00000390126 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251250Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135790
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461492Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 727070
GnomAD4 genome AF: 0.000190 AC: 29AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 21, 2024 | The c.1049C>A (p.T350N) alteration is located in exon 12 (coding exon 10) of the FBXL13 gene. This alteration results from a C to A substitution at nucleotide position 1049, causing the threonine (T) at amino acid position 350 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at